Understanding side effects before you start is one of the most important things you can do for your treatment. Patients who know what to expect, and how to manage it, are far less likely to stop a medication that could genuinely transform their health. The majority of Mounjaro side effects are gastrointestinal, temporary, and closely tied to dose increases.
The most common side effects
Source: SURMOUNT-1 and Mounjaro Summary of Product Characteristics.
| Side effect | Frequency | Typically worst during |
|---|---|---|
| Nausea | Very common (>1 in 10; ~17% to 27% depending on dose) | First 4 to 8 weeks and after each dose increase |
| Diarrhoea | Very common | First 4 weeks and after dose increases |
| Constipation | Common | Can persist; worsens with dehydration |
| Vomiting | Common | First 4 to 8 weeks |
| Indigestion | Common | Particularly after fatty or rich foods |
| Abdominal pain | Common | First 8 weeks |
| Injection site reactions | Less common (~3%) | At injection site |
How common are Mounjaro side effects?
Frequency data from SURMOUNT-1 and Mounjaro SmPC. Most side effects are temporary and improve with time.
💡 Most side effects occur during dose increases and improve within 4 to 8 weeks.
Starting at 2.5mg and increasing slowly is the most effective way to minimise them.
Source: Jastreboff AM et al. N Engl J Med 2022 (SURMOUNT-1). Mounjaro SmPC, Eli Lilly, 2024.
Why nausea happens, and why it improves
Nausea is caused by the slowing of gastric emptying. Food stays in the stomach longer than your body is accustomed to, generating a sensation similar to overeating. For most patients, the gut adapts within 4 to 8 weeks at each dose level. Nausea is typically worst in the first week at a new dose and improves progressively from there.
How to minimise GI side effects
- Eat smaller portions: Mounjaro slows gastric emptying significantly. Smaller, more frequent meals are far better tolerated than large ones.
- Avoid fatty, greasy, and processed foods: high-fat foods slow emptying further. Lean protein, vegetables, and complex carbohydrates are much better tolerated.
- Eat slowly: aim for 20 to 30 minutes per main meal, chewing thoroughly.
- Stay well hydrated: 2 to 2.5 litres of fluid daily. Dehydration worsens nausea and is a serious risk during episodes of vomiting or diarrhoea.
- Try injecting in the evening: peak nausea occurs 24 to 72 hours post-injection and may coincide with sleep for some patients. This is not universal but worth trying.
- Do not rush titration: the 4-week period at each dose exists precisely to allow your body to adjust. There is no clinical benefit to escalating faster, and a significant quality-of-life cost.
Constipation
Constipation affects approximately 11% of patients. It tends to be more persistent than nausea and is caused by significantly slowed gut motility. The most important intervention is staying well hydrated, followed by regular physical activity and a fibre-rich diet. If constipation persists, over-the-counter osmotic laxatives are safe to use alongside Mounjaro, discuss this with your pharmacist.
Hair loss
Temporary hair shedding typically begins 2 to 4 months after starting treatment and lasts 3 to 6 months. This is almost certainly telogen effluvium, a physiological stress response to rapid weight loss rather than a direct effect of tirzepatide itself. Hair growth returns to normal once weight stabilises for the vast majority of patients. Adequate protein intake (at least 1.2g per kilogram of body weight daily) and ensuring no deficiencies in iron or zinc appear to reduce the severity.
Rare but serious side effects
Pancreatitis: presents as severe upper abdominal pain radiating to the back, accompanied by nausea and vomiting. Stop Mounjaro immediately and seek urgent medical attention. Mounjaro is contraindicated in anyone with a prior history of pancreatitis.
Gallbladder disease: right-sided upper abdominal pain after eating, especially fatty meals. Rapid weight loss is associated with gallstone formation.
Acute kidney injury: a risk if prolonged vomiting or diarrhoea leads to dehydration. Seek medical attention if symptoms are severe or persistent.
Diabetic retinopathy: patients with pre-existing retinopathy should have their eyes monitored during treatment.
Injection site reactions
Redness, swelling, or itching at the injection site occurs in approximately 3% of patients. Rotate injection sites weekly, choose a different area within your thigh, abdomen, or upper arm each time.
"Starting at 2.5mg and increasing slowly is the single most effective way to minimise side effects. Most patients find symptoms improve significantly within 4 to 8 weeks at each dose level."
When to see your pharmacist or doctor
- Severe or persistent nausea preventing eating or drinking for more than 24 hours
- Frequent or prolonged vomiting (dehydration risk)
- Severe abdominal pain, particularly upper abdominal or radiating to back (pancreatitis risk)
- Right-sided upper abdominal pain after meals (gallbladder risk)
- Unexplained changes in vision
- Any side effects significantly affecting quality of life, dose adjustment is often possible, stopping is not the only option
References
- Jastreboff AM et al. N Engl J Med 2022 (SURMOUNT-1).
- Mounjaro Summary of Product Characteristics, Eli Lilly, 2024.
- MHRA Patient Safety Update 2024.
- Rubino D et al. Diabetes Obes Metab 2025 (GI tolerability in SURMOUNT 1 to 4).
Reviewed by Jimah Alsaai MPharm, GPhC 2232652, Superintendent Pharmacist, Solira.